ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2020

Jun 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2020-01-13

Reporting Person: De Backer Marianne (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-13	Common Stock	P	500	$54.95	Acquired	13000	Direct
2020-02-27	Common Stock	P	500	$35.07	Acquired	13500	Direct
2020-02-28	Common Stock	P	500	$34.39	Acquired	14000	Direct
2020-03-11	Common Stock	P	500	$28.60	Acquired	14500	Direct
2020-03-12	Common Stock	P	500	$24.80	Acquired	15000	Direct
2020-03-16	Common Stock	P	500	$23.94	Acquired	15500	Direct
2020-04-15	Common Stock	P	500	$35.40	Acquired	16000	Direct
2020-06-15	Common Stock	P	500	$31.33	Acquired	16500	Direct